May’s FDA approvals include the first at-home HPV test, a blood-based Alzheimer’s diagnostic, biosimilars, AI-enabled imaging tools, and novel therapies across cardiology, pulmonology, neurology, gastroenterology, and more.
A global survey reveals strong support for renaming PCOS, citing that the current term misrepresents the condition’s full range of reproductive, metabolic, and psychological features.
A recent study assessed the efficacy of Botulinum Toxin A injections in conjunction with pelvic floor muscle therapy for women with chronic pelvic pain, revealing interesting insights into its effectiveness compared to a placebo.
Recent study links tibolone use in menopausal hormone therapy to a 52% increased cardiovascular disease risk, emphasizing the need for tailored hormone therapy approaches and further research in BMJ.
Researchers found that universal hepatitis C screening guidelines increased testing rates in pregnant women, but overall uptake remained low, particularly among nonpregnant women.